Dr. Daniel G. Petereit, MD, FASTRO
Radiation Oncologist | Radiation Oncology
353 Fairmont Blvd Rapid City SD, 57701About
Dr. Daniel Petereit is a radiation oncologist at the Cancer Care Institute in Rapid City, South Dakota, and is the Principal Investigator of the Avera, Walking Forward Cancer Disparity Program which has been funded from the National Institute of Health since 2003. The goal of the program is to lower cancer mortality rates for Northern Plains American Indians (AIs) through patient navigation, clinical trial access, and identification of barriers to early detection and successful treatment for AIs. Published critical outcomes include establishment of trust within tribal communities, identification of barriers to cancer screenings, creation of research infrastructure, clinical-trial enrollment of 4,500 AIs (the highest in the nation) and higher completion-of-treatment and patient-satisfaction rates for patients undergoing cancer therapies. Walking Forward recently completed a smoking cessation project using nicotine replacement, counseling and text messaging to mitigate the high rates of tobacco use and tobacco induced cancers with a smoking abstinence rate of 21%. In March of 2018, Walking Forward initiated a “large scale” lung cancer screening program for those at risk for the entire population of western, SD – the Frontier population. The primary metric is to increase the utilization of low dose CTs (LDCT) rates for screen eligible smokers by targeting both primary care providers and high-risk individuals. In September 2019, we initiated a palliative care project with multiple partners including Harvard Medical School, SDSU, Great Plains tribal chairman's health board, and the 3 reservations of Western South Dakota to address the palliative care needs. Recent Walking Forward data analysis suggests American Indian cancer patients with screen-detectable cancers are now presenting with earlier stages of disease and subsequently higher cure rates. Dr. Petereit has received national recognition for his expertise in brachytherapy, cancer disparities, and clinical trials. He has had leadership roles for the American Board of Radiology (ABR), American Society for Radiation Oncology (ASTRO), many cancer cooperative groups, and is the current president of the American Brachytherapy Society (ABS). He is leading a national ABS initiative call 300 in 10 where the goal is to train 30 competent brachytherapists per year over the next 10 years. This initiative was recently highlighted in the Journal of Nature. He has published over 115 articles in peer reviewed journals and has received 15 million dollars in research funding.
Education and Training
Univ Of Sd Sch Of Med- Vermillion Sd- 1989
University of South Dakota 1989
Board Certification
RadiologyAmerican Board of RadiologyABR
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Literature analysis of high dose rate brachytherapy fractionation schedules in
- Gynecologic cancer: evolving management issues. Introduction.
- Complete surgical staging in endometrial cancer provides prognostic information only.
- Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer.
- Radiation injury from x-ray exposure during brachytherapy localization.
- Regarding Ng et al.: Defining the role of adjuvant radiotherapy for high-risk stage I endometrial patients.
- Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors.
- High-dose-rate brachytherapy-. High-dose, high-tech, and high results.
- Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.
- Cancer disparities research partnership in Lakota Country: clinical trials, patient services, and community education for the Oglala, Rosebud, and Cheyenne River Sioux tribes.
- Radiation therapy for gynecologic malignancies.
- Maintaining and acquiring brachytherapy skills.
- Community-based participatory research: providers, patient, and community in partnership to improve health disparities.
- Establishing a patient navigator program to reduce cancer disparities in the American Indian communities of Western South Dakota: initial observations and results.
- Establishing trusting partnerships for successful recruitment of American Indians to clinical trials.
Treatments
- Prostate Cancer
- Breast Cancer
- Brain Tumor
- Lung Cancer
- Colon Cancer
- Throat
- Lymphoma
- Wrinkle & Scar Improvement
- Extra Corporeal Shockwave Therapy
Dr. Daniel G. Petereit, MD, FASTRO's Practice location
Rapid City, SD 57701Get Direction
Dr. Daniel G. Petereit, MD, FASTRO's reviews
Write ReviewPatient Experience with Dr. Petereit
Media Releases
Get to know Radiation Oncologist Dr. Daniel Petereit, who serves patients in Rapid City, South Dakota.
Dr. Petereit is a board-certified radiation oncologist who manages all types of cancer, but has specialty training in brachytherapy. His primary career objective is to provide state-of-the-art cancer care for patients who live in the Midwestern region of the country, while staying academically active with partners across the country.
Currently, he is serving patients at the Regional Health John T. Vucurevich Cancer Care Institute in Rapid City, South Dakota. Located adjacent to Regional Health Rapid City Hospital, the Cancer Care Institute provides outpatient oncology services, supportive laboratory and imaging services, as well as services for related clinical research trials.
In addition to the doctor’s affiliation with Regional Health Rapid City Hospital, he is the Principal Investigator of the Walking Forward: American Indian Cancer Disparity Program, which has been receiving funding from the National Institute of Health since 2003. The goal of the program is to lower cancer mortality rates for Northern Plains American Indians (AIs) through patient navigation, clinical trial access, and identification of barriers to early detection and successful treatment. Published critical outcomes include establishment of trust within tribal communities, identification of barriers to cancer screenings, creation of research infrastructure, clinical-trial enrollment of 4,500 AIs (the highest in the nation), and higher completion-of-treatment and patient-satisfaction rates for patients undergoing cancer therapies.
Walking Forward recently completed a smoking cessation project using nicotine replacement, counseling, and text messaging to mitigate the high rates of tobacco use and tobacco-induced cancers with a smoking abstinence rate of 21%. In March of 2018, Walking Forward initiated a “large scale” lung cancer screening program for those at risk for the entire population of western South Dakota – the Frontier population. The primary metric is to increase the utilization of low dose CTs (LDCT) rates for screen-eligible smokers by targeting both primary care providers and high-risk individuals.
In September of 2019, a palliative care project was initiated with multiple partners, including Harvard Medical School, South Dakota State University, Great Plains Tribal Chairmen’s Health Board, and the 3 reservations of Western South Dakota, in order to address palliative care needs. Recent Walking Forward data analysis suggests that AI cancer patients with screen-detectable cancers are now presenting with earlier stages of disease and subsequently higher cure rates.
Inspired by his father Frank Petereit, MD, a long-time radiologist in Sioux Falls who clamored his way out of a life of poverty, Dr. Petereit earned his medical degree from the University of South Dakota Sanford School of Medicine and did his residency in radiation oncology at the University of Wisconsin. He did additional training in gynecologic oncology and head and neck cancer at the MD Anderson Cancer Center.
A Fellow of the American Society for Radiation Oncology and a Fellow of the American College of Physicians, he is board-certified in diagnostic radiology by the American Board of Radiology, which is a not for profit physician-led organization that oversees the certification and ongoing professional development of specialists in diagnostic radiology, radiation oncology, and medical physics.
For his expertise in brachytherapy, cancer disparities, and clinical trials, Dr. Petereit has received national recognition. In addition to having published over 115 articles in peer-reviewed journals and having received 15 million dollars in research funding, he has held several leadership roles with the American Board of Radiology, the American Society for Radiation Oncology, as well as many cancer cooperative groups.
Furthermore, he is the current President of the American Brachytherapy Society, leading a national initiative called 300 in 10, where the goal is to train 30 competent brachytherapists per year over the next 10 years. This initiative was highlighted in the Journal of Nature.
The mission of the ABS is to benefit patients by providing information directly to the consumer, by promoting the highest possible standards of practice of brachytherapy, as well as to benefit health care professionals by encouraging improved and continuing education for radiation oncologists and other health care professionals involved in the treatment of cancer.
Radiation oncology is a medical specialty that involves the controlled use of radiation to treat cancer. It is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. A radiation oncologist is a specialist physician who uses ionizing radiation in the treatment of cancer.
In his personal life, Dr. Petereit is happily married. He and his wife, Jean, have four children.
Recommended Articles
- Everything You Need to Know About X-Rays
What is an X-ray procedure?An X-ray is a quick diagnostic procedure to see the insides of your body. It is an essential tool used to diagnose many health conditions. It involves passing a very tiny burst of invisible electromagnetic radiation to a part of your body or your whole body and capturing...
- Treatments for Bladder Cancer
The treatment options or medications for bladder cancer depend largely on the advancement of cancer. The treatment is different for the early stage non-invasive bladder cancer and the more advanced muscle-invasive bladder cancer.During treatment, all hospitals have multidisciplinary teams (MDTs),...
- How Is Bladder Cancer Diagnosed?
In case you have symptoms of bladder cancer such as the presence of blood in the urine, you should see your doctor immediately. Your doctor will use many tests to possibly diagnose a bladder cancer and will also find out how far it has spread. Sometimes, bladder cancer may have spread to other parts...
- What Are the Side Effects of Radiation Therapy?
Radiation therapy, also known as radiotherapy, is a procedure that is used mainly to treat cancer and other conditions such as thyroid disorders, non-cancerous growths, and blood disorders. Just like other types of treatment, radiotherapy often causes side effects. The side effects generally depend...
- What Is Stage 4 Bladder Cancer?
Stage 4 bladder cancer is a bladder cancer that has spread through the bladder wall. In this stage, cancer has also invaded the lymph nodes, abdominal wall, and other body organs. This type of cancer is also known as "metastatic" bladder cancer.Stage 4 bladder cancer applies to bladder cancer that...
- The Most Common Misconceptions About Breast Cancer
There is so much information you can read online about breast cancer. Some information may be acquired in the community, friends, or family that is totally misleading or incorrect. Although not backed up with solid evidence, such information can cause a lot of media attention, which can further...
Nearby Providers
- Dr. Michael John Swartz M.D.353 Fairmont Blvd Rapid City SD 57701
- Mr. Eric Stener Eastmo MD353 Fairmont Blvd Rapid City SD 57701
- Mr. Daniel Martin Tackett MD3751 SKYLINE DR RAPID CITY SD 57701
- Dr. Ronald G Drummond MD1910 Highwood Road Rapid City SD 57701